Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)

NCT00303459 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

334

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: bosentan
DRUG: placebo

Sponsor

Actelion